{
    "organizations": [],
    "uuid": "566e1d20efd89802d439ba6d86a55e382ba84a27",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ritter-pharmaceuticals-q1-loss-per/brief-ritter-pharmaceuticals-q1-loss-per-share-0-41-idUSASC0A2FE",
    "ord_in_thread": 0,
    "title": "BRIEF-Ritter Pharmaceuticals Q1 Loss Per Share $0.41",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 15 (Reuters) - Ritter Pharmaceuticals Inc:\n* RITTER PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES\n* Q1 LOSS PER SHARE $0.41 * AS OF MARCH 31, 2018, RITTER PHARMACEUTICALS HAD CASH AND CASH EQUIVALENTS OF APPROXIMATELY $18.9 MILLION Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles. ",
    "published": "2018-05-16T04:20:00.000+03:00",
    "crawled": "2018-05-16T19:06:23.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "ritter",
        "pharmaceutical",
        "inc",
        "ritter",
        "pharmaceutical",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "provides",
        "business",
        "update",
        "q1",
        "loss",
        "per",
        "share",
        "march",
        "ritter",
        "pharmaceutical",
        "cash",
        "cash",
        "equivalent",
        "approximately",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}